New drug aims to reverse liver damage from heavy drinking

NCT ID NCT07009860

First seen Apr 01, 2026 · Last updated May 15, 2026 · Updated 6 times

Summary

This study tests a weekly injection called pemvidutide in 100 adults with alcohol-related liver disease. The goal is to see if it can reduce liver stiffness, a sign of liver damage, over 24 weeks. Participants must be overweight, have a history of heavy drinking, and have moderate liver stiffness. The study is double-blind, meaning neither participants nor doctors know who gets the real drug or a placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Peoria, Arizona, 85381, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Tucson, Arizona, 85712, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Tuscon, Arizona, 85712, United States

  • Altimmune Clinical Study Site

    RECRUITING

    North Little Rock, Arkansas, 72117, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Fresno, California, 93720, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    La Jolla, California, 92037, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Pasadena, California, 91105, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Englewood, Colorado, 80113, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Bradenton, Florida, 34201, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Doral, Florida, 33122, United States

  • Altimmune Clinical Study Site

    RECRUITING

    Doral, Florida, 33122, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Fort Myers, Florida, 33192, United States

  • Altimmune Clinical Study Site

    RECRUITING

    Miami, Florida, 33125, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Miami, Florida, 33165, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Miami Lakes, Florida, 33122, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Naples, Florida, 34102, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Orlando, Florida, 32803, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Port Orange, Florida, 32127, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Atlanta, Georgia, 30309, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Indianapolis, Indiana, 46202, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Louisville, Kentucky, 40202, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Bastrop, Louisiana, 71220, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Marrero, Louisiana, 70072, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    West Monroe, Louisiana, 71291, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Kansas City, Missouri, 64131, United States

  • Altimmune Clinical Study Site

    RECRUITING

    St Louis, Missouri, 63123, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Las Vegas, Nevada, 89106, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Manhasset, New York, 11030, United States

  • Altimmune Clinical Study Site

    RECRUITING

    New York, New York, 10032, United States

  • Altimmune Clinical Study Site

    RECRUITING

    Syracuse, New York, 13210, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Wilmington, North Carolina, 28403, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Westlake, Ohio, 44145, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Brownsville, Texas, 78520, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Dallas, Texas, 75390, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Edinburg, Texas, 78539, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Houston, Texas, 77030, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Houston, Texas, 77079, United States

  • Altimmune Clinical Study Site

    RECRUITING

    San Antonio, Texas, 78215, United States

  • Altimmune Clinical Study Site

    RECRUITING

    San Antonio, Texas, 78251, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Waco, Texas, 76710, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Richmond, Virginia, 23249, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    Seattle, Washington, 98105, United States

  • Altimmune Clinical Study Site

    NOT_YET_RECRUITING

    San Juan, Puerto Rico, 00927, Puerto Rico

Conditions

Explore the condition pages connected to this study.